|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-12-20
|
|
pubmed:abstractText |
optimal utilization of therapies effective at preventing arrhythmic death but not nonarrhythmic death, for example, the implantable cardioverter-defibrillator (ICD), is challenging in patients with concomitant heart failure (HF) and chronic kidney disease (CKD), given the association of both conditions with competing risks of death.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
161
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
204-209.e1
|
|
pubmed:meshHeading |
pubmed-meshheading:21167355-Death, Sudden, Cardiac,
pubmed-meshheading:21167355-Defibrillators, Implantable,
pubmed-meshheading:21167355-Double-Blind Method,
pubmed-meshheading:21167355-Female,
pubmed-meshheading:21167355-Follow-Up Studies,
pubmed-meshheading:21167355-Heart Failure,
pubmed-meshheading:21167355-Humans,
pubmed-meshheading:21167355-Kidney Failure, Chronic,
pubmed-meshheading:21167355-Male,
pubmed-meshheading:21167355-Middle Aged,
pubmed-meshheading:21167355-Prognosis,
pubmed-meshheading:21167355-Prospective Studies,
pubmed-meshheading:21167355-Risk Assessment,
pubmed-meshheading:21167355-Risk Factors
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease.
|
|
pubmed:affiliation |
Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA. aalsheikhali@laum.mit.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Research Support, N.I.H., Extramural
|
